Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abiraterone + ADT vs Apalutamide vs Abiraterone + Apalutamide in Advanced Prostate Cancer
NCT02867020Phase 2Completed
- Sponsor
- Latin American Cooperative Oncology Group
- Start
- Oct 2017
- Primary completion
- Oct 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of apalutamide, abiraterone in prostate cancer (PCa), sponsored by Latin American Cooperative Oncology Group. Started Oct 2017; status: completed.
02
Drugs
apalutamideabiraterone
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02867020.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02867020.